
Carcinoembryonic antigen (CEA) is widely used as a tumour biomarker in human medicine, but its applicability in dogs with pulmonary neoplasms remains poorly defined. This retrospective study evaluated serum CEA concentrations in dogs with primary and metastatic pulmonary neoplasms. Thirty-seven dogs with stored serum available were allocated to four groups: G1, primary pulmonary neoplasms treated by lobectomy; G2, primary pulmonary neoplasms not treated surgically; G3, pulmonary metastases from mammary neoplasms; and G4, pulmonary metastases from other extrathoracic neoplasms. CEA was measured by ELISA at diagnosis (D0) and 30 days after the start of treatment (D30). Concentrations differed among groups at D0 (p = 0.023) and D30 (p = 0.004), being highest in G3. Receiver operating characteristic analysis yielded areas under the curve of 0.798 at D0 (cut-off ≥ 0.90 ng/mL; sensitivity, 69.2%; specificity, 83.3%) and 0.938 at D30 (cut-off ≥ 1.05 ng/mL; sensitivity, 90.9%; specificity, 100%). Higher CEA was associated with an increased risk of death when all dogs were analysed together. CEA shows potential as a complementary biomarker for identifying dogs with pulmonary metastases of mammary origin, whereas its value for early monitoring of therapeutic response and as an independent prognostic marker was limited.
Common carotid artery velocity–time integral (CCA-VTI) may offer an accessible peripheral measurement for hemodynamic assessment, but its relationship with aortic velocity–time integral (Ao-VTI) in dogs remains unclear. This prospective observational pilot study evaluated their association, agreement, technical feasibility, and acquisition times in 51 unsedated client-owned dogs. A single investigator sequentially obtained both measurements using pulsed-wave Doppler, averaging three consecutive cardiac cycles. No preload-modifying intervention was performed. Data were evaluated using Pearson correlation, linear regression, Bland–Altman analysis, and the Wilcoxon matched-pairs signed-rank test. Technically adequate CCA-VTI measurements were obtained in 48 dogs (94.1%), which were included in the paired analyses. CCA-VTI was positively correlated with Ao-VTI (r = 0.7021, p < 0.001; R2 = 0.4929). There was no statistically significant difference in acquisition time between CCA-VTI and Ao-VTI. CCA-VTI acquisition was feasible in most unsedated dogs and showed a significant positive association with Ao-VTI. However, variability between individual measurements precludes assuming interchangeability. Further validation against independent blood-flow measurements and during controlled preload interventions is needed before clinical use for systemic flow estimation or fluid-responsiveness assessment.
Periparturient dairy cows with high body condition scores are susceptible to metabolic stress and inflammation. This study evaluated whether a single prepartum dose of meloxicam modifies systemic biomarkers and liver and subcutaneous white adipose tissue (sWAT) transcriptomes. Seventy-two Holstein cows were assigned to control or meloxicam groups (36/group); meloxicam (0.5 mg/kg) or saline was administered subcutaneously 14 ± 1 days before expected calving. Twelve cows (6/group) underwent longitudinal blood sampling and prepartum and postpartum tissue biopsy. Postpartum disease, culling, pregnancy, and milk-yield outcomes were summarized descriptively. Treatment × time interactions were detected for non-esterified fatty acids, aspartate aminotransferase, serum amyloid A, haptoglobin, and insulin, but not γ-glutamyl transferase. Direct postpartum comparisons identified only five differentially expressed genes in each tissue. Within-group prepartum-to-postpartum comparisons identified 116 liver and 808 sWAT genes meeting differential expression criteria in the meloxicam but not the control group. Enriched functions included regulation of monocyte chemotaxis in the liver and respiratory burst, B-cell receptor, Toll-like receptor, and natural killer cell signaling in sWAT. Descriptively, meloxicam-treated cows had fewer postpartum disease events and a higher pregnancy proportion, with similar milk yield. These findings suggest that prepartum meloxicam may modify inflammatory and innate immune adaptation during the transition period; adequately powered studies are needed to confirm the clinical outcomes.
This exploratory study was designed to investigate associations between AM-containing high-concentrate diets and immune markers in Dumeng lambs and to generate hypotheses regarding concurrent changes in rumen fermentation, liquid-associated rumen microbial community structure, and metabolic profiles. Eighteen healthy male Dumeng lambs were randomly assigned to three groups with six lambs per group (n = 6). The CON group served as the control, while the T1 and T2 groups were supplemented with 1% and 2% AM, respectively. The results showed that compared with CON, lambs fed AM-containing diets had higher ruminal NH3-N (10.88 vs. 12.01 and 12.10 mg/100 mL, p < 0.01) and TVFA (73.78 vs. 85.39 and 87.22 mmol/L, p < 0.05) concentrations, lower acetate proportion (52.16% vs. 47.64% and 46.55%) and acetate-to-propionate ratio (p < 0.01), and higher butyrate proportion in the 1% and 2% AM groups (5.58% vs. 8.55 and 9.31%, p < 0.01). Endpoint-level immune effects survived BH-FDR correction (q < 0.05); Tukey-adjusted pairwise comparisons showed that T2 lambs had lower IL-6 (58.97 vs. 91.35 pg/mL), TNF-α (137.80 vs. 182.38 pg/mL), rumen LPS (109.33 vs. 141.25 ng/mL), and serum LPS (59.67 vs. 81.07 ng/mL), and higher IL-10 (123.14 vs. 87.88 pg/mL), TP (73.50 vs. 67.72 g/L), ALB (28.69 vs. 24.47 g/L), IgA (15.42 vs. 8.52 μg/mL), and IgG (18.38 vs. 11.73 μg/mL) than CON. Exploratory 16S rRNA analysis showed nominally lower Proteobacteria and higher Shuttleworthia in T2; however, no taxon survived BH-FDR correction (q ≥ 0.05), and ANCOM W and LEfSe LDA results are exploratory sensitivity findings only. Exploratory metabolomics suggested associations with purine and nucleotide metabolism; KEGG analysis used uncorrected p values and is hypothesis-generating only. These correlational findings indicate that AM-containing high-concentrate diets are associated with changes in several immune markers; because diets also differed in ingredients other than AM, causality, clinical benefits, and the independent effect of AM remain to be established.
Feline herpesvirus-1 (FHV-1) is an important pathogen causing feline upper respiratory tract disease and poses a serious threat to the health of domestic cats as well as captive and wild felids. Vaccination remains a crucial strategy for controlling FHV-1 infection. Feline trivalent live vaccines are the most widely used and effective products, and all use the FHV-1 F2 strain as the vaccine component. However, no diagnostic method is currently available to distinguish F2 vaccine strains from other FHV-1 strains. In this study, we targeted the A397G SNP in the UL44 gene and developed a MGB probe-based duplex allele-specific qPCR for simultaneous detection and differential diagnosis of FHV-1 F2-associated strains and non-F2 strains. This assay showed no cross-reactivity with other major feline pathogens or heterologous animal herpesviruses. The 95% limit of detection (LOD) was 11.5 copies/μL for FHV-1 F2-associated strains and 4.33 copies/μL for non-F2 strains. Intra- and inter-assay coefficients of variation were both below 2.5%. Evaluation using clinical samples and a blinded simulated-panel confirmed that this assay could accurately determine F2-associated allele. In conclusion, this assay is a rapid, specific, sensitive, and viable diagnostic tool to distinguish the FHV-1 F2 vaccine strain from field isolates, in conjunction with definitive vaccination history and epidemiological information.